Summary
The human colon adenocarcinoma HT29-D4 cell line is an interesting model for studies on epithelial cell differentiation. Undifferentiated cells are malignant proliferating cells, whereas differentiated cells act like epithelial polarized cells. In the present study, we first characterized the action of taxoids on the microtubular network of HT29-D4 cells according to the state of differentiation. Microtubular bundles were found in undifferentiated cells but not in differentiated cells, even with 500-fold higher taxoid concentrations for 96 h. This finding led us to study changes in microtubules according to the polarity status of the cell. E-MAP-115 was expressed only in differentiated cells; expression of β-tubulin isotypes was altered in them relative to undifferentiated cells. Classes I, II, III, IVa and IVb isotypes were expressed in both phenotypes; however, differentiated epithelial cells displayed a specific increase in class III β-tubulin. Thus, the increase in expression of this β-tubulin isotype in differentiated cells is not restricted to neuronal cells. Moreover, these expression changes may reflect a higher stability of microtubular network in differentiated cells, which may explain the lower activity of anti-microtubule agents, independently of the mitotic process. These results indicate that the composition of microtubules should be considered as one of the criteria involved in the response of tumour cells to chemotherapy with anti-microtubule agents.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Alexander, J. E., Hunt, D. F., Lee, M. K., Shabanowitz, J., Michel, H., Berlin, S. C., Macdonald, R. J., Rebhun, L. I. & Franckfurter, A. (1991). Characterization of posttranslational modifications in neuron-specific class III β-tubulin by mass spectrometry. Proc Natl Acad Sci USA 88: 4685–4689.
Arruda, M., Cocchiaro, C. A., Nelson, C. M., Grinnel, C. M., Janssen, B., Haupt, A. & Barlozzari, T. (1995). LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. Cancer Res 55: 3085–3092.
Baas, P. W. & Black, M. B. (1990). Individual microtubules in the axon consist of domains that differ in both composition and stability. J Cell Biol 111: 495–509.
Bulinski, J. C. & Borisy, G. G. (1979). Self-assembly of Hela tubulin and the identification of Hela microtubule proteins. Proc Natl Acad Sci USA 76: 293–297.
Bulinski, J. C. & Gundersen, G. G. (1991). Stabilization and post-translational modification of microtubules during cellular morphogenesis. BioEssays 13: 285–293.
Carles, G., Braguer, D., Sabeur, G. & Briand, C. (1998). Effect of combining anti-microtubule agents at low doses on differentiated and undifferentiated human colon cancer cell lines. Anticancer Drugs 9: 209–221.
Cassimeris, L. (1993). Regulation of microtubule dynamic instability in living cells. Cell Motil Cytoskeleton 26: 275–281.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thicyanate–phenol–chloroform extraction. Anal Biochem 162: 156–159.
Cowan, N. J., Lewis, S. A., Sarkar, S. & Gu, W. (1986). Functional versatility of mammalian β-tubulin isotypes. In The Cytoskeleton in Cell Differentiation and Development, Maccioni RB and Arechaga J, IRL Press: Oxford 157–166.
Derry, W. B., Wilson, L., Khan, I. A., Luduena, R. F. & Jordan, M. A. (1997). Taxol differentially modulates the dynamics of microtubule assembled from unfractionated and purified β-tubulin isotypes. Biochemistry 6: 3554–3562.
Dieras, V., Fumoleau, P., Bourgeois, H., Misset, J. L., Azli, N. & Pouillart, T. (1996). Taxoids in combination chemotherapy for metastatic breast cancer. Anticancer Drugs 7: 47–52.
Dimanche-Boitrel, M. T., Garrido, C. & Chauffert, B. (1993). Kinetic resistance to anticancer agents. Cytotechnology 12: 5596–5602.
Falconer, M. M., Echeverri, C. J. & Brown, D. L. (1992). Differential sorting of β-tubulin isotypes into colchicine-stable microtubules during neuronal and muscle differentiation of embryonal carcinoma cells. Cell Motil Cytoskeleton 21: 313–325.
Fantini, J., Abadie, B., Tirard, A., Remy, L., Ripert, J. P., El Battari, A. & Marvaldi, J. (1986). Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. J Cell Sci 83: 235–249.
Fantini, J., Rognoni, J. B., Culouscou, J. M., Pommier, G., Marvaldi, J. & Tirard, A. (1989). Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29-D4 cells. J Cell Physiol 141: 126–134.
Garcia, P., Braguer, D., Carles, G., El Khiari, S., Barra, Y., De Ines, C., Barasoain, I. & Briand, C. (1994). Comparative effects of taxol and taxotere on two different human carcinoma cell lines. Cancer Chemother Pharmacol 34: 335–343.
Gard, D. L. & Kirshner, M. W. (1985). A polymer-dependent increase in phosphorylation of β-tubulin accompanies differentiation of mouse neuroblastoma cell line. J Cell Biol 100: 764–774.
Gurland, G. & Gundersen, G. G. (1995). Stable detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts. J Cell Biol 131: 1275–1290.
Hirokawa, N. (1994). Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol 6: 74–81.
Horwitz, S. B., Cohen, D., Rao, S., Ringel, I., Shen, H. J. & Yang, C. P. (1993). Taxol: mechanisms of action and resistance. J Natl Cancer Inst Monogr 15: 55–61.
Jordan, M. A. & Wilson, L. (1998). Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10: 123–130.
Joschi, H. C. & Cleveland, D. W. (1989). Differential utilization of β-tubulin isotypes in differentiating neurites. J Cell Biol 109: 663–673.
Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M. & Horwitz, S. B. (1997). Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes. Cancer Res 100: 1282–1293.
Luduena, R. F. (1993). Are tubulin isotypes functionally significant?. Mol Biol Cell 4: 445–457.
Manfredi, J. J. & Horwitz, S. B. (1984). Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 25: 83–125.
Mary, J., Redeker, V., Le Caer, J. P., Prome, J. G. & Rossier, J. (1994). Class I and IVaβ-tubulin isotypes expressed in adult mouse brain are glutamylated. FEBS Lett 353: 89–94.
Masson, D. & Kreis, T. E. (1993). Identification and molecular characterization of E-MAP-115, a novel microtubule-associated protein predominantly expressed in epithelial cells. J Cell Biol 123: 357–371.
Masson, D. & Kreis, T. E. (1995). Binding of E-MAP-115 to microtubules is regulated by cell cycle-dependent phosphorylation. J Cell Biol 131: 1015–1024.
Matus, A. (1988). Microtubule associated proteins: their potential role in determining neuronal morphology. Annu Rev Neurosci 11: 29–44.
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L. & Davidson, M. (1996). Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334: 1–6.
Ranganathan, S., Benetatos, C. A., Colarusso, P. J., Dexter, D. W. & Hudes, G. R. (1998). Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells. Br J Cancer 77: 562–566.
Rognoni, J. B., Pichard, V., Honore, S., Rigot, V., Lehmann, M., Roccabianca, M., Carles, G., Luis, J., Marvaldi, J. & Briand, C. (1998). Convergent effects of growth factors, hormones, and fibronectin are necessary for the enterocyte differentiation of a colon adenocarcinoma cell line (HT29-D4). Differentiation 63: 305–317.
Rowinsky, E. K., Onetto, N. & Canetta, R. A. (1992). Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 19: 646–662.
Rudiger, M., Plessman, U., Kloppel, K. D., Wehland, J. & Weber, K. (1992). Class II tubulin, the major brain β-tubulin isotype is polyglutamylated on glutamic acid residue 435. FEBS Lett 308: 101–105.
Schibler, M. J. & Cabral, F. (1986). Taxol-dependent mutants of chinese hamster ovary cells with alterations of α- and β-tubulin. J Cell Biol 102: 1522–1531.
Shelden, E. & Wadsworth, P. (1993). Observation and quantification of individual microtubule behavior in vivo: microtubule dynamics are cell-type specific. J Cell Biol 120: 935–945.
Simons, K. & Wandinger-Ness, A. (1990). Polarized sorting in epithelia. Cell 62: 207–210.
Wadsworth, P. & Bottaro, D. P. (1996). Microtubule dynamic turnover is suppressed during polarization and stimulated in hepatocyte growth factor scattered Madin-Darby Canine Kidney epithelial cells. Cell Motil Cytoskeleton 35: 225–236.
Wang, X. M., Peloquin, J. G., Zhai, Y., Bulinski, J. C. & Borisy, G. G. (1996). Removal of MAP4 from microtubules in vivo produces no observable phenotype at the cellular level. J Cell Biol 132: 345–357.
Wilson, L. & Jordan, M. A. (1995). Microtubule dynamics: taking aim at a moving target. Chem Biol 2: 569–573.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Carles, G., Braguer, D., Dumontet, C. et al. Differentiation of human colon cancer cells changes the expression of β-tubulin isotypes and MAPs. Br J Cancer 80, 1162–1168 (1999). https://doi.org/10.1038/sj.bjc.6690481
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690481
Keywords
This article is cited by
-
Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis
Scientific Reports (2022)
-
Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection
Analytical and Bioanalytical Chemistry (2012)
-
Differential expression of glu-tubulin in relation to mammary gland disease
Virchows Archiv (2010)
-
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
BMC Cancer (2008)
-
Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype
British Journal of Cancer (2007)